Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update on the Phase 1/Phase 2 safety and efficacy study of NUV-1511 in adults with advanced solid tumors, including HER2-nega…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered iv in Patients With PDAC [Phase 1]
Phase 1 study evaluating the safety, pharmacokinetics, and preliminary efficacy of intravenous OMO-103, a Myc inhibitor, in patients with me…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating HRS-4642 in combination with other antitumor therapies for locally advanced or metastatic pancreatic c…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer [NA]
An update on a clinical trial evaluating computed tomography to aid diagnosis in patients with pancreatic or hepatobiliary cancers. The stud…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Study of LY4170156 in Participants With Selected Advanced Solid Tumors [Phase 1]
An early-phase study evaluating LY4170156 in selected advanced solid tumors is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer [Phase 1]
First-in-human phase 1 study of TORL-2-307-ADC in participants with advanced cancer, including gastric cancer, pancreatic cancer, and gastro…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Study of SGN-MesoC2 in Advanced Solid Tumors [Phase 1]
Seagen is conducting a Phase 1 study of SGN-MesoC2 in advanced solid tumors, including non-small cell lung cancer, ovarian cancer, pancreati…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating nivolumab and ipilimumab with radiation therapy in microsatellite-stable and MSI-high colorectal cancer and pancrea…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: The Seven Trial: Exploiting the Unfolded Protein Response [Phase 1]
A Phase 1 clinical trial called The Seven Trial is exploring exploitation of the unfolded protein response in metastatic pancreatic cancer, …
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors. [Phase 2]
Phase 2 multicenter prospective study assessing arterial infusion chemotherapy and embolization combined with dual immune checkpoint inhibit…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer [NA]
This clinical trial update notes that a study combining stereotactic body radiation with tumor treating fields is currently recruiting for l…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 study evaluating the combination of Niraparib and Dostarlimab (TSR-042) in BRCA-mutated unresectable or metastatic cancers including…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
LOTUS-CC is an observational study at the University of Rochester aimed at uncovering subtypes of cancer cachexia in patients with advanced …
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Phase I Clinical Study of IX001 TCR-T Injection in the Treatment of Advanced Pancreatic Cancer Patients With KRAS G12V Mutation [Phase 1]
This clinical trial entry reports a Phase I study of IX001 TCR-T Injection for advanced pancreatic cancer with KRAS G12V mutation; recruitme…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Construction of a Predictive Model for the Efficacy of Chemoprevention Combined With Targeted Therapy in Pancreatic Cancer
This document outlines a clinical trial aimed at developing a predictive model to assess the efficacy of chemoprevention when combined with …
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial [Phase 2]
Phase 2 clinical trial update for pancreatic cancer investigating adaptive neoadjuvant chemotherapy. Recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: High Dose Omeprazole in Patients With Pancreatic Cancer [EARLY_Phase 1]
A Phase 1 clinical trial is evaluating high-dose omeprazole in patients with exocrine pancreatic cancer; the study is currently in the recru…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer [Phase 2, Phase 3]
Clinical trial update for the PLATINUM study evaluating second-line platinum-based chemotherapy for metastatic BRCA1/2- or PALB2-associated …
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer [Phase 2]
Phase 2 randomized trial evaluating all-trans retinoic acid (ATRA) in a novel drug combination for pancreatic cancer; the trial is currently…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery [Phase 1]
A Phase 1 study evaluating personalized tumor vaccines in combination with a PD-L1 blocker for resectable pancreatic cancer; the trial is cu…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer [Phase 2]
This document provides an update on the Phase 2 SMMART-ACT precision medicine trial. It targets patients with advanced breast, ovarian, panc…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer [EARLY_Phase 1]
Early-phase feasibility trial comparing oral ketamine to placebo for anxiety in patients with pancreatic cancer; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: WATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer Treatment
This clinical trial update notes that the study examining WATD and cancer-related fatigue in patients undergoing anti-cancer treatment is cu…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" [NA]
MD Anderson Cancer Center is conducting a clinical trial to evaluate the association between health care provider–assessed ECOG performance …
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients
A real-world study in China is recruiting to evaluate irinotecan hydrochloride liposome injection II for pancreatic cancer.